Key takeaways
- Ketamine can lift depression and calm PTSD within hours, but certain medical and psychiatric conditions place patients at unacceptably high risk.
- Absolute disqualifiers include uncontrolled high blood pressure, active psychosis, pregnancy, and severe cardiovascular disease.
- Relative contraindications, such as mild hypertension, past substance misuse, or liver disease, require extra screening rather than an automatic “no.”
Ketamine’s ability to relieve resistant depression, suicidal thinking, and certain pain syndromes has changed modern psychiatry. Yet the same surge of sympathetic activity that boosts mood can also spike blood pressure and heart workload. In the wrong physiologic setting, that surge may tip from therapeutic to dangerous. Careful screening is therefore the first treatment step, not an administrative hurdle.
How ketamine works in brief
At sub-anesthetic doses, ketamine blocks N-methyl-D-aspartate (NMDA) receptors, increases glutamate release, and sparks a cascade that strengthens neural connections. Symptom relief often appears within hours and can last days to weeks. Those rapid shifts come with transient rises in heart rate and blood pressure along with perceptual changes, effects that explain many of ketamine’s exclusion criteria.
When ketamine is simply unsafe
Clinical protocols differ by clinic, but certain red-line conditions are nearly universal. Instead of a long bullet list, see how each factor undermines ketamine’s safety profile.
Uncontrolled hypertension
Ketamine routinely elevates blood pressure by 20–25 mmHg during an infusion. Patients whose resting systolic pressure already tops 160 mmHg face a compounded surge that can precipitate stroke or aortic dissection. Tight control with medication is required before therapy can be considered.
Acute or unstable cardiovascular disease
A recent heart attack, symptomatic arrhythmia, or decompensated heart failure marks ketamine unsafe. Case reports describe acute systolic heart failure after non-clinical ketamine misuse, underscoring the drug’s cardiac stress in vulnerable hearts.
Current pregnancy or breastfeeding
Animal data suggest neuro-developmental risks, and human evidence remains sparse. Most clinics either defer treatment or insist on formal obstetric clearance. A recent multi-center survey found more than 90 percent of U.S. ketamine clinics list pregnancy as a formal contraindication.
Active psychosis or untreated bipolar mania
Dissociative side effects can worsen delusions or trigger manic cycling. Trials that won FDA approval for esketamine excluded patients with schizophrenia or active psychosis, and professional societies follow suit.
Elevated intracranial pressure or aneurysm
Ketamine transiently raises intracranial pressure; any pre-existing elevation, tumor, hydrocephalus, large aneurysm, can become dangerous.
Uncontrolled substance use disorder, especially ketamine misuse
Because ketamine’s rapid mood lift carries abuse potential, ongoing misuse of alcohol, stimulants, opioids, or ketamine itself disqualifies treatment until sobriety is established.
Relative contraindications
Not every concern prompts an automatic “no.” Some patients qualify after optimization or specialist clearance.
- Mild to moderate hypertension that responds to medication adjustment.
- Stable coronary artery disease with normal exercise tolerance and a recent cardiologist note.
- Past substance misuse now in sustained remission and documented by toxicology screens.
- Controlled seizure disorders on stable antiepileptic doses.
- Liver disease (e.g., hepatitis C) if baseline enzymes sit below two times upper normal and coagulation profile is normal.
- Obstructive sleep apnea if continuous positive airway pressure (CPAP) is in regular use.
Each factor requires individualized discussion, but none guarantee exclusion when risks are balanced against severe, treatment-resistant symptoms.
The screening process
Vital-sign check: Blood pressure, pulse, and oxygen saturation establish a baseline. Any systolic reading above 140 mmHg prompts medical review.
Lab review: Recent complete blood count, comprehensive metabolic panel, and if indicated, liver function tests. Advanced liver disease may slow ketamine clearance.
Medication reconciliation: Certain benzodiazepines blunt ketamine’s antidepressant effect; monoamine-oxidase inhibitors raise blood-pressure risk.
Psychiatric assessment: Clinician screens for suicidal ideation, psychosis, mania, or dissociative disorders.
Substance-use screen: Urine toxicology and a timeline follow-back interview help rule out active misuse.
Pregnancy test: Required for all people of child-bearing potential, repeated per clinic policy.
Veterans Affairs
A clear-to-proceed decision typically combines objective data with clinical judgment. When findings land in the gray zone, the provider may request clearance notes from cardiology, obstetrics, or addiction specialists.
Why these exclusions exist
Ketamine’s sympathetic “kick” raises catecholamines, pushing blood pressure and heart rate higher for about 30 minutes. Healthy vessels stretch to absorb the surge; diseased vessels may rupture. Similarly, ketamine’s brief elevation of intracranial pressure is harmless for most brains but dangerous for anyone with existing pressure problems.
On the psychiatric side, ketamine’s dissociation can feel liberating when anchored by stable reality testing, yet it can fuel paranoia in psychosis or tip bipolar mood toward mania. Screening is less about rigid rule following and more about matching the medicine to the right nervous system.
How to improve your candidacy
If you land in the relative-risk camp, small health upgrades can tip the balance toward eligibility.
Work with your primary-care physician to tighten blood-pressure control. A single additional medication or dose tweak often lowers readings in two weeks.
Document sobriety. Attend counseling, join mutual-aid groups, and provide toxicology screens that show consistent negative results.
Get cardiac clearance. A stress test or echocardiogram demonstrating stable function reassures your ketamine provider.
Address sleep apnea. Nightly CPAP use reduces cardiovascular strain, making ketamine’s transient increase safer.
What if you remain disqualified?
Being ruled out for ketamine therapy does not close all doors. Alternative evidence-based options include:
Electroconvulsive therapy (ECT): Still the gold standard for severe, drug-resistant depression, particularly with psychotic features.
Repetitive transcranial magnetic stimulation (rTMS): Non-invasive brain stimulation cleared by the FDA for depression and OCD.
Augmentation strategies: Atypical antipsychotics, lithium, or thyroid hormone can boost antidepressant response.
Intensive psychotherapy: Dialectical behavior therapy or cognitive processing therapy can stand alone or pair with medication.
Your clinician’s job is to guide you toward the safest, most effective path, ketamine when a match, alternatives when not.
Frequently asked questions
Is age a disqualifier?
No. Chronological age is less important than cardiovascular and psychiatric stability. Many clinics treat patients in their seventies after thorough clearance.
Can I restart ketamine after substance-use relapse?
Possibly, once sobriety is re-established and monitored, often in coordination with addiction specialists.
Does oral or nasal ketamine have different exclusion rules?
The physiologic stress is lower at sublingual and intranasal doses but not zero. Most clinics apply the same absolute contraindications.
Safety first, relief second
Screening out high-risk candidates protects not only those individuals but the reputation and future of ketamine therapy itself. If you are unsure where you stand, book an assessment. Our team at Avid Sports Medicine combines psychiatric expertise, medical oversight, and evidence-based protocols to determine candidacy and tailor alternatives when needed. Clear answers, yes, no, or not yet, bring peace of mind and point you toward the next right step.